Результаты поиска - William C. Gruber

Отмена результатов
  1. 1
    Prevention of otitis media in children with live attenuated influenza vaccine given intranasally

    Prevention of otitis media in children with live attenuated influenza vaccine given intranasally по Robert B. Belshe, William C. Gruber

    Опубликовано 2000
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Predicting the Probability for Falls in Community-Dwelling Older Adults

    Predicting the Probability for Falls in Community-Dwelling Older Adults по Anne Shumway‐Cook, Margaret Baldwin, Nayak L. Polissar, William C. Gruber

    Опубликовано 1997
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    Incidence of and Risk Factors for Falls Following Hip Fracture in Community-dwelling Older Adults

    Incidence of and Risk Factors for Falls Following Hip Fracture in Community-dwelling Older Adults по Anne Shumway‐Cook, Marcia A. Ciol, William C. Gruber, Cynthia A. Robinson

    Опубликовано 2005
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    The impact of human vaccines on bacterial antimicrobial resistance. A review

    The impact of human vaccines on bacterial antimicrobial resistance. A review по Kathrin U. Jansen, William C. Gruber, Raphael Simon, James Wassil, Annaliesa S. Anderson

    Опубликовано 2021
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  5. 5
    Comparison of Results of Detection of Rhinovirus by PCR and Viral Culture in Human Nasal Wash Specimens from Subjects with and without Clinical Symptoms of Respiratory Illness

    Comparison of Results of Detection of Rhinovirus by PCR and Viral Culture in Human Nasal Wash Specimens from Subjects with and without Clinical Symptoms of Respiratory Illness по Peter F. Wright, Anne M. Deatly, Ruth A. Karron, Robert B. Belshe, Jian Shi, William C. Gruber, Yuwei Zhu, Valerie B. Randolph

    Опубликовано 2007
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Illness Severity, Viral Shedding, and Antibody Responses in Infants Hospitalized with Bronchiolitis Caused by Respiratory Syncytial Virus

    Illness Severity, Viral Shedding, and Antibody Responses in Infants Hospitalized with Bronchiolitis Caused by Respiratory Syncytial Virus по Peter F. Wright, William C. Gruber, M. Robert Peters, George Reed, Yuwei Zhu, F W Robinson, Shanita D. Coleman-Dockery, Barney S. Graham

    Опубликовано 2002
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial

    Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial по Ron Dagan, Scott D. Patterson, Christine Juergens, David Greenberg, Noga Givon‐Lavi, Nurith Porat, Alejandra Gurtman, William C. Gruber, Daniel A. Scott

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults

    Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults по Masanari Shiramoto, Ryuzo Hanada, Christine Juergens, Yasuko Shoji, Mizuki Yoshida, Barry Ballan, David Cooper, William C. Gruber, Daniel A. Scott, Beate Schmöele-Thoma

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Efficacy and Safety of 1 and 2 Doses of Live Attenuated Influenza Vaccine in Vaccine-Naive Children

    Efficacy and Safety of 1 and 2 Doses of Live Attenuated Influenza Vaccine in Vaccine-Naive Children по Humberto Bracco Neto, Calil K. Farhat, Miguel Tregnaghi, Shabir A. Madhi, Ahmad Razmpour, Giuseppe Palladino, Margaret Small, William C. Gruber, Bruce D. Forrest

    Опубликовано 2009
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults

    Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults по Jose A Suaya, Qin Jiang, Daniel A. Scott, William C. Gruber, Chris Webber, Beate Schmöele-Thoma, Cassandra Hall-Murray, Luis Jódar, Raúl Istúriz

    Опубликовано 2018
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years

    A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years по Nicholas Kitchin, Shon Remich, James T. Peterson, Yahong Peng, William C. Gruber, Kathrin U. Jansen, Michael W. Pride, Annaliesa S. Anderson, Charles Knirsch, Chris Webber

    Опубликовано 2019
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    Efficacy of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus That of 7-Valent PCV (PCV7) Against Nasopharyngeal Colonization of Antibiotic-Nonsusceptible<i>Streptococcus pneumoniae</i>

    Efficacy of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus That of 7-Valent PCV (PCV7) Against Nasopharyngeal Colonization of Antibiotic-Nonsusceptible<i>Streptococcus pne... по Ron Dagan, Christine Juergens, James Trammel, Scott D. Patterson, David Greenberg, Noga Givon‐Lavi, Nurith Porat, Alejandra Gurtman, William C. Gruber, Daniel A. Scott

    Опубликовано 2014
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  13. 13
    Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children

    Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children по Bruce D. Forrest, Michael W. Pride, Andrew J. Dunning, María Rosario Capeding, Tawee Chotpitayasunondh, John S. Tam, Ruth Rappaport, John H. Eldridge, William C. Gruber

    Опубликовано 2008
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    A post hoc assessment of duration of protection in CAPiTA (Community Acquired Pneumonia immunization Trial in Adults)

    A post hoc assessment of duration of protection in CAPiTA (Community Acquired Pneumonia immunization Trial in Adults) по Scott D. Patterson, Chris Webber, Michael A. Patton, Wayne Drews, Susanne M. Huijts, Marieke Bolkenbaas, William C. Gruber, Daniel A. Scott, Marc J. M. Bonten

    Опубликовано 2016
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    Evaluation of Live Attenuated Influenza Vaccines in Children 6-18 Months of Age: Safety, Immunogenicity, and Efficacy

    Evaluation of Live Attenuated Influenza Vaccines in Children 6-18 Months of Age: Safety, Immunogenicity, and Efficacy по William C. Gruber, Robert B. Belshe, James C. King, John J. Treanor, Pedro A. Piedra, Peter F. Wright, George Reed, Elizabeth M. Anderson, Frances K. Newman

    Опубликовано 1996
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Pediatric Vaccinations in Canada

    Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Pediatric Vaccinations in Canada по Otto G. Vanderkooi, David W. Scheifele, Douglas Girgenti, Scott A. Halperin, Scott D. Patterson, William C. Gruber, Emilio A. Emini, Daniel A. Scott, James D. Kellner

    Опубликовано 2011
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines

    The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines по Peter F. Wright, Ruth A. Karron, Robert B. Belshe, Jian Shi, Valerie B. Randolph, Peter L. Collins, Alice O’Shea, William C. Gruber, Brian R. Murphy

    Опубликовано 2007
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged ≥2 Years: An Open-Label Study

    Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoi... по Catherine Cordonnier, Per Ljungman, Christine Juergens, Johan Maertens, Dominik Selleslag, Vani Sundaraiyer, Peter C. Giardina, Keri Clarke, William C. Gruber, Daniel A. Scott, Beate Schmöele-Thoma

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies

    SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies по Elizabeth Begier, David Seiden, Michael A. Patton, Edward T. Zito, Joseph M. Severs, David Cooper, Joseph Eiden, William C. Gruber, Kathrin U. Jansen, Annaliesa S. Anderson, Alejandra Gurtman

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine по Lisa A. Jackson, Alejandra Gurtman, Kathryn Rice, Karlis Pauksens, Richard N. Greenberg, Thomas R. Jones, Daniel A. Scott, Emilio A. Emini, William C. Gruber, Beate Schmöele-Thoma

    Опубликовано 2013
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: